Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1324852.RAb0sjx27Ssyfs3GOh814oDwSACGvLdP9Zv0_FSGYpP6w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1324852.RAb0sjx27Ssyfs3GOh814oDwSACGvLdP9Zv0_FSGYpP6w130_assertion type Assertion NP1324852.RAb0sjx27Ssyfs3GOh814oDwSACGvLdP9Zv0_FSGYpP6w130_head.
- NP1324852.RAb0sjx27Ssyfs3GOh814oDwSACGvLdP9Zv0_FSGYpP6w130_assertion description "[To investigate the prevalence of potential mutations in the gene encoding HKII, we used the polymerase chain reaction (PCR) to amplify each of the 18 exons of the HKII gene from genomic DNA derived from 59 subjects: 25 insulin-resistant probands with clinical features of the type A syndrome and 34 NIDDM subjects enrolled in the United Kingdom Prospective Study of Therapies of NIDDM (UKPDS) who represented the highest percentile of fasting hyperinsulinemia in the UKPDS population of 5,098 subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1324852.RAb0sjx27Ssyfs3GOh814oDwSACGvLdP9Zv0_FSGYpP6w130_provenance.
- NP1324852.RAb0sjx27Ssyfs3GOh814oDwSACGvLdP9Zv0_FSGYpP6w130_assertion evidence source_evidence_literature NP1324852.RAb0sjx27Ssyfs3GOh814oDwSACGvLdP9Zv0_FSGYpP6w130_provenance.
- NP1324852.RAb0sjx27Ssyfs3GOh814oDwSACGvLdP9Zv0_FSGYpP6w130_assertion SIO_000772 7883122 NP1324852.RAb0sjx27Ssyfs3GOh814oDwSACGvLdP9Zv0_FSGYpP6w130_provenance.
- NP1324852.RAb0sjx27Ssyfs3GOh814oDwSACGvLdP9Zv0_FSGYpP6w130_assertion wasDerivedFrom befree-2016 NP1324852.RAb0sjx27Ssyfs3GOh814oDwSACGvLdP9Zv0_FSGYpP6w130_provenance.
- NP1324852.RAb0sjx27Ssyfs3GOh814oDwSACGvLdP9Zv0_FSGYpP6w130_assertion wasGeneratedBy ECO_0000203 NP1324852.RAb0sjx27Ssyfs3GOh814oDwSACGvLdP9Zv0_FSGYpP6w130_provenance.